Recent publications
Article
Loke, J, Labopin, M, Craddock, C, Socié, G, Gedde‐Dahl, T, Blaise, D, Forcade, E, Salmenniemi, U, Huynh, A, Versluis, J, Yakoub‐Agha, I, Labussière‐Wallet, H, Maertens, J, Passweg, J, Bulabois, CE, Gabellier, L, Mielke, S, Castilla‐Llorente, C, Deconinck, E, Brissot, E, Nagler, A, Ciceri, F & Mohty, M 2024, 'Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation study', Cancer. https://doi.org/10.1002/cncr.35308
Loke, J, Upasani, V, Gaskell, C, Fox, S, Fletcher, R, Thomas, C, Hopkins, L, Kumari, A, Tang, T, Yafai, E, Boucher, R, Homer, V, Toth, A, Chan, YLT, Randall, K, Rider, T, O'nions, J, Drew, V, Pillai, A, Dungarwalla, M, Murray, D, Khan, A, Wandroo, F, Moore, S, Krishnamurthy, P, Huang, YJ, Knapper, S, Byrne, J, Zhao, R, Craddock, C, Parry, H, Moss, P, Stanworth, SJ & Lowe, DM 2023, 'Defective T‐cell response to COVID‐19 vaccination in acute myeloid leukaemia and myelodysplastic syndromes', British Journal of Haematology, vol. 202, no. 3, pp. 498-503. https://doi.org/10.1111/bjh.18894
Loke, J, McCarthy, N, Jackson, A, Siddique, S, Hodgkinson, A, Mason, J, Crawley, C, Gilleece, M, Peniket, A, Protheroe, R, Salim, R, Tholouli, E, Wilson, K, Andrew, G, Dillon, R, Khan, N, Potter, V, Krishnamurthy, P, Craddock, C & Freeman, S 2023, 'Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS', Blood Advances, vol. 7, no. 14, pp. 3666-3676. https://doi.org/10.1182/bloodadvances.2022009493
Loke, J, Labopin, M, Craddock, C, Cornelissen, JJ, Labussière-Wallet, H, Wagner-Drouet, EM, Van Gorkom, G, Schaap, NPM, Kröger, NM, Veelken, JH, Rovira, M, Menard, AL, Bug, G, Bazarbachi, A, Giebel, S, Brissot, E, Nagler, A, Esteve, J & Mohty, M 2022, 'Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia', Cancer, vol. 128, no. 15, pp. 2922-2931. https://doi.org/10.1002/cncr.34268
Loke, J, Metzner, M, Boucher, R, Jackson, A, Hopkins, L, Pavlu, J, Tholouli, E, Drummond, M, Peniket, A, Bishop, R, Fox, S, Vyas, P & Craddock, C 2021, 'Combination romidepsin and azacitidine therapy is well tolerated and clinically active in adults with high-risk acute myeloid leukaemia ineligible for intensive chemotherapy', British Journal of Haematology. https://doi.org/10.1111/bjh.17823
Craddock, C, Jackson, A, Loke, J, Siddique, S, Hodgkinson, A, Mason, J, Andrew, G, Nagra, S, Malladi, R, Peniket, A, Gilleece, M, Salim, R, Tholouli, E, Potter, V, Crawley, C, Wheatley, K, Protheroe, R, Vyas, P, Hunter, A, Parker, A, Wilson, K, Pavlu, J, Byrne, J, Dillon, R, Khan, N, Mccarthy, N & Freeman, SD 2020, 'Augmented reduced-intensity regimen does not improve postallogeneic transplant outcomes in acute myeloid leukemia', Journal of Clinical Oncology . https://doi.org/10.1200/JCO.20.02308
Assi, SA, Imperato, MR, Coleman, DJL, Pickin, A, Potluri, S, Ptasinska, A, Chin, PS, Blair, H, Cauchy, P, James, SR, Zacarias-cabeza, J, Gilding, LN, Beggs, A, Clokie, S, Loke, JC, Jenkin, P, Uddin, A, Delwel, R, Richards, SJ, Raghavan, M, Griffiths, MJ, Heidenreich, O, Cockerill, PN & Bonifer, C 2019, 'Subtype-specific regulatory network rewiring in acute myeloid leukemia', Nature Genetics, vol. 51, no. 1, pp. 151-162. https://doi.org/10.1038/s41588-018-0270-1
Loke, J, Chin, PS, Keane, P, Pickin, A, Assi, S, Ptasinska, A, Imperato, M, Cockerill, P & Bonifer, C 2018, 'C/EBPα overrides epigenetic reprogramming by oncogenic transcription factors in acute myeloid leukemia', Blood Advances, vol. 2, no. 3, pp. 271-284. https://doi.org/10.1182/bloodadvances.2017012781, https://doi.org/10.1182/bloodadvances.2017012781
Malaker, SA, Penny, SA, Steadman, LG, Myers, PT, Loke, JC, Raghavan, M, Bai, DL, Shabanowitz, J, Hunt, DF & Cobbold, M 2017, 'Identification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia', Cancer immunology research, vol. 5, no. 5, pp. 376-384. https://doi.org/10.1158/2326-6066.CIR-16-0280
Loke, J, Assi, SA, Imperato, MR, Ptasinska, A, Cauchy, P, Grabovska, Y, Soria, NM, Raghavan, M, Delwel, HR, Cockerill, PN, Heidenreich, O & Bonifer, C 2017, 'RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t(8;21) and t(3;21) AML', Cell Reports, vol. 19, no. 8, pp. 1654-1668. https://doi.org/10.1016/j.celrep.2017.05.005
Loke, J, Akiki, S, Borrow, J, Ewing, J, Bokhari, S, Chandra, D, Arrazi, J, Hazlewood, P, Arthur, K, Walsh, J, Membwange, Y, Wandroo, F, Watts, A, Borg, A, Brock, K, Ferguson, P, Craddock, C, Griffiths, M & Raghavan, M 2015, 'Acquired Isodisomy on Chromosome 13 at diagnosis results in impaired overall survival in Patients with FLT3-ITD mutant Acute Myeloid Leukaemia', Leukemia, vol. 29, no. 12, pp. 2404-2407. https://doi.org/10.1038/leu.2015.148
Review article
Kinsella, FAM, Maroto, MAL, Loke, J & Craddock, C 2024, 'Strategies to reduce relapse risk in patients undergoing allogeneic stem cell transplantation for acute myeloid leukaemia', British Journal of Haematology. https://doi.org/10.1111/bjh.19463
Loke, J, Buka, R & Craddock, C 2021, 'Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: Who, When, and How?', Frontiers in immunology, vol. 12, 659595. https://doi.org/10.3389/fimmu.2021.659595
Loke, J, Vyas, H & Craddock, C 2021, 'Optimizing Transplant Approaches and Post-Transplant Strategies for Patients With Acute Myeloid Leukemia', Frontiers in Oncology, vol. 11, 666091. https://doi.org/10.3389/fonc.2021.666091
Loke, J, Malladi, R, Moss, P & Craddock, C 2019, 'The role of allogeneic stem cell transplantation in the management of acute myeloid leukaemia: a triumph of hope and experience', British Journal of Haematology, vol. 188, no. 1, pp. 129-146. https://doi.org/10.1111/bjh.16355
View all publications in research portal